Carcinoid heart disease: a guide for screening and timing of surgical intervention

被引：0
作者：
E. A. Hart
T. A. Meijs
R. C. A. Meijer
K. M. Dreijerink
M. E. Tesselaar
C. A. de Groot
G. D. Valk
S. A. J. Chamuleau
机构：
[1] University Medical Centre Utrecht,Department of Cardiology
[2] University Medical Centre Utrecht,Department of Cardiothoracic Surgery
[3] University Medical Centre Utrecht,Department of Endocrine Oncology
[4] Antoni van Leeuwenhoek Hospital,Department of Cardiology
[5] Slotervaart Medical Centre,undefined
来源：
Netherlands Heart Journal | 2017年 / 25卷
关键词：
Carcinoid heart disease; Hedinger syndrome; Valvular disease; Screening; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally with regard to screening for CaHD and the optimal timing for surgery. Although limited evidence is available on this matter, a trend towards early surgery and subsequent reduced mortality has been observed. In this review we provide an overview of the current understanding and propose a protocol to guide cardiologists in the screening for CaHD and the timing of referral to a specialised surgical centre.
引用
收藏
页码：471 / 478
页数：7
相关论文
共 155 条
  • [1] Yao JC(2008)One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 3063-3072
  • [2] Hassan M(2008)Neuroendocrine tumor epidemiology: contrasting Norway and North America Cancer 113 2655-2664
  • [3] Phan A(2005)Current status of gastrointestinal carcinoids Gastroenterology 128 1717-1751
  • [4] Hauso O(2015)Carcinoid heart disease: from pathophysiology to treatment – ’something in the way it moves’ Neuroendocrinology 101 263-273
  • [5] Gustafsson BI(2004)Carcinoid heart disease: presentation, diagnosis, and management Heart 90 1224-1228
  • [6] Kidd M(1993)Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients Circulation 87 1188-1196
  • [7] Modlin IM(2011)Risk factors for the development and progression of carcinoid heart disease Am J Cardiol 107 1221-1226
  • [8] Kidd M(2003)Carcinoid heart disease: the role of urinary 5‑hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor Cancer 97 1609-1615
  • [9] Latich I(2008)Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century Am J Cardiol 101 378-381
  • [10] Grozinsky-Glasberg S(2002)Metastatic carcinoid tumor to the heart: Echocardiographic-pathologic study of 11 patients J Am Coll Cardiol 40 1328-1332
12345678910